S&P 500   3,271.03 (-3.53%)
DOW   26,519.95 (-3.43%)
QQQ   271.64 (-3.90%)
AAPL   111.20 (-4.63%)
MSFT   202.68 (-4.96%)
FB   267.67 (-5.51%)
GOOGL   1,510.80 (-5.51%)
AMZN   3,162.78 (-3.76%)
TSLA   406.02 (-4.39%)
NVDA   505.08 (-5.75%)
BABA   307.94 (-2.90%)
CGC   18.34 (-1.71%)
GE   7.42 (+4.51%)
MU   50.00 (-3.77%)
AMD   76.40 (-3.14%)
T   26.50 (-1.56%)
F   7.70 (-2.78%)
ACB   3.83 (-4.25%)
GILD   58.72 (-2.15%)
NFLX   486.24 (-0.55%)
NIO   27.51 (-3.27%)
BA   148.14 (-4.57%)
DIS   118.47 (-3.93%)
S&P 500   3,271.03 (-3.53%)
DOW   26,519.95 (-3.43%)
QQQ   271.64 (-3.90%)
AAPL   111.20 (-4.63%)
MSFT   202.68 (-4.96%)
FB   267.67 (-5.51%)
GOOGL   1,510.80 (-5.51%)
AMZN   3,162.78 (-3.76%)
TSLA   406.02 (-4.39%)
NVDA   505.08 (-5.75%)
BABA   307.94 (-2.90%)
CGC   18.34 (-1.71%)
GE   7.42 (+4.51%)
MU   50.00 (-3.77%)
AMD   76.40 (-3.14%)
T   26.50 (-1.56%)
F   7.70 (-2.78%)
ACB   3.83 (-4.25%)
GILD   58.72 (-2.15%)
NFLX   486.24 (-0.55%)
NIO   27.51 (-3.27%)
BA   148.14 (-4.57%)
DIS   118.47 (-3.93%)
S&P 500   3,271.03 (-3.53%)
DOW   26,519.95 (-3.43%)
QQQ   271.64 (-3.90%)
AAPL   111.20 (-4.63%)
MSFT   202.68 (-4.96%)
FB   267.67 (-5.51%)
GOOGL   1,510.80 (-5.51%)
AMZN   3,162.78 (-3.76%)
TSLA   406.02 (-4.39%)
NVDA   505.08 (-5.75%)
BABA   307.94 (-2.90%)
CGC   18.34 (-1.71%)
GE   7.42 (+4.51%)
MU   50.00 (-3.77%)
AMD   76.40 (-3.14%)
T   26.50 (-1.56%)
F   7.70 (-2.78%)
ACB   3.83 (-4.25%)
GILD   58.72 (-2.15%)
NFLX   486.24 (-0.55%)
NIO   27.51 (-3.27%)
BA   148.14 (-4.57%)
DIS   118.47 (-3.93%)
S&P 500   3,271.03 (-3.53%)
DOW   26,519.95 (-3.43%)
QQQ   271.64 (-3.90%)
AAPL   111.20 (-4.63%)
MSFT   202.68 (-4.96%)
FB   267.67 (-5.51%)
GOOGL   1,510.80 (-5.51%)
AMZN   3,162.78 (-3.76%)
TSLA   406.02 (-4.39%)
NVDA   505.08 (-5.75%)
BABA   307.94 (-2.90%)
CGC   18.34 (-1.71%)
GE   7.42 (+4.51%)
MU   50.00 (-3.77%)
AMD   76.40 (-3.14%)
T   26.50 (-1.56%)
F   7.70 (-2.78%)
ACB   3.83 (-4.25%)
GILD   58.72 (-2.15%)
NFLX   486.24 (-0.55%)
NIO   27.51 (-3.27%)
BA   148.14 (-4.57%)
DIS   118.47 (-3.93%)
Log in
NYSE:MCK

McKesson Stock Forecast, Price & News

$144.10
-5.11 (-3.42 %)
(As of 10/28/2020 05:06 PM ET)
Add
Compare
Today's Range
$143.89
Now: $144.10
$148.74
50-Day Range
$146.23
MA: $151.15
$156.67
52-Week Range
$112.60
Now: $144.10
$172.18
Volume919,904 shs
Average Volume2.45 million shs
Market Capitalization$23.37 billion
P/E Ratio25.69
Dividend Yield1.13%
Beta0.76
McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. It operates in three segments: U.S. Pharmaceutical and Specialty Solutions, European Pharmaceutical Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs, as well as other healthcare-related products; and offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices. It also provides specialty pharmaceutical solutions for pharmaceutical manufacturers; and medical-surgical supply distribution, logistics, and other services to healthcare providers. In addition, the company operates retail pharmacy chains in Europe and Canada, as well as supports independent pharmacy networks within North America and Europe; and supplies integrated pharmacy management systems, automated dispensing systems, and related services to retail, outpatient, central fill, specialty, and mail order pharmacies. Further, it provides software and analytics, network solutions, and technology-enabled services. The company serves retail national accounts, including national and regional chains, food and drug combinations, mail order pharmacies, and mass merchandisers; independent retail pharmacies; and institutional healthcare providers, such as hospitals, health systems, integrated delivery networks, and long-term care providers, as well as pharmaceutical manufacturers. McKesson Corporation was founded in 1833 and is headquartered in San Francisco, California.
Read More
McKesson logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.4Community Rank: 3.1Dividend Strength: 1.7Insider Behavior: 1.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.88 out of 5 stars

Industry, Sector and Symbol

Industry Drugs, proprietaries, & sundries
Sub-IndustryHealth Care Distributors
SectorMedical
CUSIP58155Q10
Phone972-446-4800
Employees80,000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$231.05 billion
Cash Flow$20.18 per share
Book Value$30.01 per share

Profitability

Net Income$900 million

Miscellaneous

Market Cap$23.37 billion
Next Earnings Date11/3/2020 (Confirmed)
OptionableOptionable
$144.10
-5.11 (-3.42 %)
(As of 10/28/2020 05:06 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive MCK News and Ratings via Email

Sign-up to receive the latest news and ratings for MCK and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











McKesson (NYSE:MCK) Frequently Asked Questions

How has McKesson's stock been impacted by Coronavirus?

McKesson's stock was trading at $135.17 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, MCK stock has increased by 6.6% and is now trading at $144.10.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of McKesson?

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for McKesson in the last year. There are currently 3 hold ratings and 10 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for McKesson
.

When is McKesson's next earnings date?

McKesson is scheduled to release its next quarterly earnings announcement on Tuesday, November 3rd 2020.
View our earnings forecast for McKesson
.

How can I listen to McKesson's earnings call?

McKesson will be holding an earnings conference call on Tuesday, November 3rd at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were McKesson's earnings last quarter?

McKesson Co. (NYSE:MCK) posted its quarterly earnings data on Monday, August, 3rd. The company reported $2.77 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $2.35 by $0.42. The business earned $55.68 billion during the quarter, compared to analysts' expectations of $54.16 billion. McKesson had a net margin of 0.40% and a return on equity of 42.33%. The firm's revenue was down .1% compared to the same quarter last year. During the same period in the prior year, the company posted $3.31 EPS.
View McKesson's earnings history
.

How often does McKesson pay dividends? What is the dividend yield for McKesson?

McKesson declared a quarterly dividend on Wednesday, July 29th. Investors of record on Tuesday, September 1st will be paid a dividend of $0.42 per share on Thursday, October 1st. This represents a $1.68 dividend on an annualized basis and a yield of 1.17%. The ex-dividend date is Monday, August 31st. This is an increase from McKesson's previous quarterly dividend of $0.41.
View McKesson's dividend history
.

What guidance has McKesson issued on next quarter's earnings?

McKesson issued an update on its FY21 earnings guidance on Monday, August, 3rd. The company provided earnings per share guidance of $14.70-15.50 for the period, compared to the Thomson Reuters consensus EPS estimate of $14.39.

What price target have analysts set for MCK?

13 brokers have issued 1-year price targets for McKesson's stock. Their forecasts range from $147.00 to $204.00. On average, they anticipate McKesson's share price to reach $179.08 in the next year. This suggests a possible upside of 24.3% from the stock's current price.
View analysts' price targets for McKesson
.

Are investors shorting McKesson?

McKesson saw a drop in short interest during the month of October. As of October 15th, there was short interest totaling 1,840,000 shares, a drop of 12.8% from the September 30th total of 2,110,000 shares. Based on an average daily trading volume, of 1,060,000 shares, the days-to-cover ratio is currently 1.7 days. Approximately 1.1% of the company's shares are sold short.
View McKesson's Short Interest
.

Who are some of McKesson's key competitors?

What other stocks do shareholders of McKesson own?

Based on aggregate information from My MarketBeat watchlists, some companies that other McKesson investors own include The Walt Disney (DIS), Johnson & Johnson (JNJ), Gilead Sciences (GILD), CVS Health (CVS), AbbVie (ABBV), Bank of America (BAC), AT&T (T), JPMorgan Chase & Co. (JPM), UnitedHealth Group (UNH) and Home Depot (HD).

Who are McKesson's key executives?

McKesson's management team includes the following people:
  • Mr. John H. Hammergren, Chairman & CEO (Age 60)
  • Britt J. Vitalone, CFO & Exec. VP (Age 50)
  • Ms. Lori A. Schechter, Chief Compliance Officer, Exec. VP & Gen. Counsel (Age 57)
  • Mr. Jorge L. Figueredo, Exec. VP & Chief HR Officer (Age 58)
  • Mr. Bansi Nagji, Exec. VP and Chief Strategy & Bus. Devel. Officer (Age 54)

What is McKesson's stock symbol?

McKesson trades on the New York Stock Exchange (NYSE) under the ticker symbol "MCK."

Who are McKesson's major shareholders?

McKesson's stock is owned by many different institutional and retail investors. Top institutional shareholders include LSV Asset Management (0.99%), Scharf Investments LLC (0.52%), Signature Estate & Investment Advisors LLC (0.11%), Standard Life Aberdeen plc (0.11%), State of New Jersey Common Pension Fund D (0.07%) and Envestnet Asset Management Inc. (0.06%). Company insiders that own McKesson stock include Brian S Tyler, Brian Scott Tyler, Britt J Vitalone, Lori A Schechter, M Christine Jacobs, Marie L/Ca Knowles and Sundeep G Reddy.
View institutional ownership trends for McKesson
.

Which major investors are selling McKesson stock?

MCK stock was sold by a variety of institutional investors in the last quarter, including KBC Group NV, State of Alaska Department of Revenue, Assenagon Asset Management S.A., Scharf Investments LLC, LSV Asset Management, CWM LLC, Redpoint Investment Management Pty Ltd, and Fortem Financial Group LLC. Company insiders that have sold McKesson company stock in the last year include Brian S Tyler, Britt J Vitalone, Lori A Schechter, Marie L/Ca Knowles, and Sundeep G Reddy.
View insider buying and selling activity for McKesson
.

Which major investors are buying McKesson stock?

MCK stock was bought by a variety of institutional investors in the last quarter, including Campbell Capital Management Inc., Alberta Investment Management Corp, CX Institutional, Tributary Capital Management LLC, Stoneridge Investment Partners LLC, NewFocus Financial Group LLC, Envestnet Asset Management Inc., and Beese Fulmer Investment Management Inc..
View insider buying and selling activity for McKesson
.

How do I buy shares of McKesson?

Shares of MCK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is McKesson's stock price today?

One share of MCK stock can currently be purchased for approximately $144.10.

How big of a company is McKesson?

McKesson has a market capitalization of $23.37 billion and generates $231.05 billion in revenue each year. The company earns $900 million in net income (profit) each year or $14.95 on an earnings per share basis. McKesson employs 80,000 workers across the globe.

What is McKesson's official website?

The official website for McKesson is www.mckesson.com.

How can I contact McKesson?

McKesson's mailing address is 6555 STATE HWY 161, IRVING TX, 75039. The company can be reached via phone at 972-446-4800 or via email at [email protected]

This page was last updated on 10/28/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.